...
首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Evaluation of efficacy and tolerability of nitrofurantoin versus ciprofloxacin in patients of urinary tract infection: a comparative study
【24h】

Evaluation of efficacy and tolerability of nitrofurantoin versus ciprofloxacin in patients of urinary tract infection: a comparative study

机译:呋喃妥因与环丙沙星对尿路感染患者的疗效和耐受性评估:一项比较研究

获取原文
           

摘要

Background: UTIs are one of the most common infectious diseases encountered in out-patient departments on day to day basis. Nitrofurantoin and Ciprofloxacin are most commonly used antibiotics in the treatment of UTI. The present study was done to compare the efficacy and tolerability of nitrofurantoin and ciprofloxacin in patients of urinary tract infection. Methods: This prospective, open, randomized, parallel group, comparative study was conducted on 60 patients presenting with acute/uncomplicated or recurrent urinary tract infection in the outpatient Department of Urology, Rajindra Hospital attached to Govt. Medical College, Patiala, Punjab. They were divided into two groups, Group I and Group II of 30 cases each. Group I patients were put on Nitrofurantoin and Group II patients were put on Ciprofloxacin. Initially 100 patients were enrolled but only those who showed growth of uropathogens on baseline urine culture or those who completed the treatment were included in the study. The primary outcome measure was microbiological eradication on post treatment urine culture. Results: The age range of the patients in Group I and Group II was 19 to 68 years (43.40±14.58 years) and 20-60 years (39.77±13.49 years) respectively. The total no. of males and females who participated in this study were 32 (53.33%) and 28 (46.66%) respectively. The most common uropathogen associated with uncomplicated UTI was E. coli (80%), other organisms detected were Klebsiella species (16.67%), Staphylococcus aureus (3.33%) and Providencia (3.33%). Post treatment urine culture results showed significant difference between two groups, 5 patients (16.67 %) in case of Group I and 14 patients (46.67%) in case of Group II showed growth of micro-organisms post treatment. P-value comes out to be 0.017 which is significant. Conclusions: In this era of super bugs, nitrofurantoin is more efficacious than ciprofloxacin in the treatment of UTI. E. coli was found to be major organism causing UTI. Ciprofloxacin is less effective due to increasing antibiotic resistance among uropathogens. Both the drugs were well tolerated, no major significant adverse effects were encountered.
机译:背景:尿路感染是门诊日常遇到的最常见的传染病之一。呋喃妥因和环丙沙星是UTI治疗中最常用的抗生素。本研究旨在比较硝基呋喃妥因和环丙沙星在尿路感染患者中的疗效和耐受性。方法:这项前瞻性,开放,随机,平行分组的比较研究在Govt附设的门诊部的拉金德拉医院门诊部对60例患有急性/非复杂性或复发性尿路感染的患者进行了比较。旁遮普邦Patiala医学院。他们分为两组,第一组和第二组各30例。第一组患者使用呋喃妥因,第二组患者使用环丙沙星。最初招募了100例患者,但仅包括那些在基线尿培养中显示尿毒症生长的患者或完成治疗的患者。主要结果指标是治疗后尿培养的微生物根除。结果:第一组和第二组患者的年龄范围分别为19至68岁(43.40±14.58岁)和20-60岁(39.77±13.49岁)。总数参与这项研究的男性和女性分别为32(53.33%)和28(46.66%)。与简单尿路感染相关的最常见尿路病原是大肠杆菌(80%),检测到的其他生物是克雷伯菌属(16.67%),金黄色葡萄球菌(3.33%)和普罗维登西亚(3.33%)。治疗后尿培养结果显示两组之间有显着差异,第一组为5例(16.67%),第二组为14例(46.67%),表明治疗后微生物的生长。 P值显示为0.017,这是显着的。结论:在这个超级细菌的时代,呋喃妥因在治疗UTI方面比环丙沙星更有效。发现大肠杆菌是引起UTI的主要生物。环丙沙星疗效不佳,因为尿路致病菌之间的抗生素耐药性增加。两种药物均具有良好的耐受性,未遇到重大的重大不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号